{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:53:19Z","timestamp":1784008399313,"version":"3.55.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12958-018-0347-9","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T04:02:24Z","timestamp":1522814544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice"],"prefix":"10.1186","volume":"16","author":[{"given":"Bo","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Wai","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Ying","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Wai","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Chiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"key":"347_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/humrep\/den398","volume":"24","author":"JA Garcia-Velasco","year":"2009","unstructured":"Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod. 2009;24:496\u2013501.","journal-title":"Hum Reprod"},{"key":"347_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.fertnstert.2008.04.056","volume":"92","author":"C Meuleman","year":"2009","unstructured":"Meuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D, D'Hooghe T. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009;92:68\u201374.","journal-title":"Fertil Steril"},{"key":"347_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0960-0760(02)00260-1","volume":"83","author":"J Kitawaki","year":"2002","unstructured":"Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol. 2002;83:149\u201355.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"347_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0002-9378(15)30003-X","volume":"14","author":"JA Sampson","year":"1927","unstructured":"Sampson JA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927;14:422\u201369.","journal-title":"Am J Obstet Gynecol"},{"key":"347_CR5","first-page":"4474","volume":"83","author":"K Zeitoun","year":"1998","unstructured":"Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, Johns A, Meng L, Putman M, Carr B, Bulun SE. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab. 1998;83:4474\u201380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 3","key":"347_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/humrep\/11.suppl_3.53","volume":"11","author":"PJ van der Linden","year":"1996","unstructured":"van der Linden PJ. Theories on the pathogenesis of endometriosis. Human Reprod (Oxford, England). 1996;11(Suppl 3):53\u201365.","journal-title":"Human Reprod (Oxford, England)"},{"key":"347_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJM200107263450407","volume":"345","author":"DL Olive","year":"2001","unstructured":"Olive DL, Pritts EA. Treatment of endometriosis. N Engl J Med. 2001;345:266\u201375.","journal-title":"N Engl J Med"},{"key":"347_CR8","doi-asserted-by":"crossref","unstructured":"Fuldeore MJ, Soliman AM. Prevalence and symptomatic burden of diagnosed endometriosis in the United States: National Estimates from a cross-sectional survey of 59,411 women. Gynecol Obstet Investig. 2016;","DOI":"10.1159\/000452660"},{"key":"347_CR9","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/humrep\/det284","volume":"28","author":"AA De Graaff","year":"2013","unstructured":"De Graaff AA, D'Hooghe TM, GAJ D, Dirksen CD, Hummelshoj L, Simoens S, Bokor A, Brandes I, Brodszky V, Canis M, et al. The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey. Hum Reprod. 2013;28:2677\u201385.","journal-title":"Hum Reprod"},{"key":"347_CR10","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1080\/00016340903108308","volume":"88","author":"B Fagervold","year":"2009","unstructured":"Fagervold B, Jenssen M, Hummelshoj L, Moen MH. Life after a diagnosis with endometriosis - a 15 years follow-up study. Acta Obstet Gynecol Scand. 2009;88:914\u20139.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"347_CR11","doi-asserted-by":"crossref","unstructured":"Dunselman GaJ, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, et al: ESHRE guideline: management of women with endometriosis. Hum Reprod 2014, 29:400\u2013412.","DOI":"10.1093\/humrep\/det457"},{"key":"347_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.prp.2016.10.010","volume":"213","author":"J Bateman","year":"2017","unstructured":"Bateman J, Bougie O, Singh S, Islam S. Histomorphological changes in endometriosis in a patient treated with ulipristal: a case report. Pathol Res Pract. 2017;213:79\u201381.","journal-title":"Pathol Res Pract"},{"key":"347_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0028-2243(87)90008-6","volume":"26","author":"FJ Cornillie","year":"1987","unstructured":"Cornillie FJ, Puttemans P, Brosens IA. Histology and ultrastructure of human endometriotic tissues treated with dydrogesterone (Duphaston). Eur J Obstet Gynecol Reprod Biol. 1987;26:39\u201355.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"347_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00404-009-1301-z","volume":"282","author":"AE Schindler","year":"2009","unstructured":"Schindler AE, Henkel A, Moore C, Oettel M. Effect and safety of high-dose dienogest (20 mg\/day) in the treatment of women with endometriosis. Arch Gynecol Obstet. 2009;282:507\u201314.","journal-title":"Arch Gynecol Obstet"},{"key":"347_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1056\/NEJMoa1103182","volume":"366","author":"J Donnez","year":"2012","unstructured":"Donnez J, Tatarchuk TF, Bouchard P, Puscasiu L, Zakharenko NF, Ivanova T, Ugocsai G, Mara M, Jilla MP, Bestel E, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012;366:409\u201320.","journal-title":"N Engl J Med"},{"key":"347_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.fertnstert.2015.04.025","volume":"104","author":"GE Courtoy","year":"2015","unstructured":"Courtoy GE, Donnez J, Marbaix E, Dolmans M-M. In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment. Fertil Steril. 2015;104:426\u201334. e421","journal-title":"Fertil Steril"},{"key":"347_CR17","doi-asserted-by":"publisher","first-page":"e0140795","DOI":"10.1371\/journal.pone.0140795","volume":"10","author":"N Esber","year":"2015","unstructured":"Esber N, Le Billan F, Resche-Rigon M, Loosfelt H, Lomb\u00e8s M, Chabbert-Buffet N. Ulipristal acetate inhibits progesterone receptor isoform A-mediated human breast Cancer proliferation and BCl2-L1 expression. PLoS One. 2015;10:e0140795.","journal-title":"PLoS One"},{"key":"347_CR18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1576\/toag.8.4.229.27272","volume":"8","author":"D Mansour","year":"2006","unstructured":"Mansour D. Use of the new progestogens in contraception and gynaecology. Obstet Gynaecol. 2006;8:229\u201334.","journal-title":"Obstet Gynaecol"},{"key":"347_CR19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0015-0282(16)56991-X","volume":"62","author":"CE Overton","year":"1994","unstructured":"Overton CE, Lindsay PC, Johal B, Collins SA, Siddle NC, Shaw RW, Barlow DH. A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis. Fertil Steril. 1994;62:701\u20137.","journal-title":"Fertil Steril"},{"key":"347_CR20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.fertnstert.2017.01.003","volume":"107","author":"RF Casper","year":"2017","unstructured":"Casper RF. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril. 2017;107:533\u20136.","journal-title":"Fertil Steril"},{"key":"347_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0015-0282(97)00193-3","volume":"68","author":"P Vercellini","year":"1997","unstructured":"Vercellini P, Cortesi I, Crosignani PG. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril. 1997;68:393\u2013401.","journal-title":"Fertil Steril"},{"key":"347_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/molehr\/7.4.341","volume":"7","author":"H Okada","year":"2001","unstructured":"Okada H, Nakajima T, Yoshimura T, Yasuda K, Kanzaki H. The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro. Mol Hum Reprod. 2001;7:341\u20137.","journal-title":"Mol Hum Reprod"},{"key":"347_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/humupd\/dms026","volume":"18","author":"MW Laschke","year":"2012","unstructured":"Laschke MW, Menger MD. Anti-angiogenic treatment strategies for the therapy of endometriosis. Hum Reprod Update. 2012;18:682\u2013702.","journal-title":"Hum Reprod Update"},{"key":"347_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jri.2016.12.002","volume":"119","author":"T Makabe","year":"2017","unstructured":"Makabe T, Koga K, Miyashita M, Takeuchi A, Sue F, Taguchi A, Urata Y, Izumi G, Takamura M, Harada M, et al. Drospirenone reduces inflammatory cytokines, vascular endothelial growth factor (VEGF) and nerve growth factor (NGF) expression in human endometriotic stromal cells. J Reprod Immunol. 2017;119:44\u20138.","journal-title":"J Reprod Immunol"},{"key":"347_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0014-2999(99)00765-7","volume":"386","author":"M Nakamura","year":"1999","unstructured":"Nakamura M, Katsuki Y, Shibutani Y, Oikawa T. Dienogest, a synthetic steroid, suppresses both embryonic and tumor-cell-induced angiogenesis. Eur J Pharmacol. 1999;386:33\u201340.","journal-title":"Eur J Pharmacol"},{"key":"347_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.gmit.2015.01.011","volume":"5","author":"T Tsuchiya","year":"2016","unstructured":"Tsuchiya T, Katagiri Y, Maemura T, Hayata E, Fukuda Y, Kitamura M, Morita M. Preoperative dienogest to improve the surgical field of view in resectoscopic surgery. Gynecol Minim Invasive Ther. 2016;5:16\u20139.","journal-title":"Gynecol Minim Invasive Ther"},{"key":"347_CR27","doi-asserted-by":"crossref","unstructured":"Pelch KE, Sharpe-Timms KL, Nagel SC. Mouse model of surgically-induced endometriosis by auto-transplantation of uterine tissue. J Vis Exp. 2012:e3396.","DOI":"10.3791\/3396"},{"key":"347_CR28","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2353\/ajpath.2009.081011","volume":"175","author":"M Bacci","year":"2009","unstructured":"Bacci M, Capobianco A, Monno A, Cottone L, Di Puppo F, Camisa B, Mariani M, Brignole C, Ponzoni M, Ferrari S, et al. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol. 2009;175:547\u201356.","journal-title":"Am J Pathol"},{"key":"347_CR29","first-page":"220","volume":"83","author":"D Aoki","year":"1994","unstructured":"Aoki D, Katsuki Y, Shimizu A, Kakinuma C, Nozawa S. Successful heterotransplantation of human endometrium in SCID mice. Obstet Gynecol. 1994;83:220\u20138.","journal-title":"Obstet Gynecol"},{"key":"347_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10456-012-9299-4","volume":"16","author":"CC Wang","year":"2013","unstructured":"Wang CC, Xu H, GCW M, Zhang T, Chu KO, Chu CY, JTY C, Li G, He YX, Qin L, et al. Prodrug of green tea epigallocatechin-3-gallate (pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice. Angiogenesis. 2013;16:59\u201369.","journal-title":"Angiogenesis"},{"key":"347_CR31","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/humrep\/den417","volume":"24","author":"H Xu","year":"2009","unstructured":"Xu H, Lui WT, Chu CY, Ng PS, Wang CC, Rogers MS. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Hum Reprod. 2009;24:608\u201318.","journal-title":"Hum Reprod"},{"key":"347_CR32","volume-title":"Center for Drug Evaluation and Research (CDER)","author":"Rockville","year":"2005","unstructured":"Rockville. Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. In: Center for Drug Evaluation and Research (CDER); 2005."},{"key":"347_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1365-2265.2007.03148.x","volume":"69","author":"CR Oliveira","year":"2008","unstructured":"Oliveira CR, Salvatori R, Nobrega LM, Carvalho EO, Menezes M, Farias CT, Britto AV, Pereira RM, Aguiar-Oliveira MH. Sizes of abdominal organs in adults with severe short stature due to severe, untreated, congenital GH deficiency caused by a homozygous mutation in the GHRH receptor gene. Clin Endocrinol. 2008;69:153\u20138.","journal-title":"Clin Endocrinol"},{"key":"347_CR34","doi-asserted-by":"crossref","unstructured":"Cardiff RD, Miller CH, Munn RJ: Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc 2014, 2014:pdb.prot073411.","DOI":"10.1101\/pdb.prot073411"},{"key":"347_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/07853899909019260","volume":"31","author":"VM Kahari","year":"1999","unstructured":"Kahari VM, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med. 1999;31:34\u201345.","journal-title":"Ann Med"},{"key":"347_CR36","first-page":"135","volume":"12","author":"SA Rabbani","year":"1998","unstructured":"Rabbani SA. Metalloproteases and urokinase in angiogenesis and tumor progression. In Vivo. 1998;12:135\u201342.","journal-title":"In Vivo"},{"key":"347_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10555-005-5131-6","volume":"24","author":"D Sheppard","year":"2005","unstructured":"Sheppard D. Integrin-mediated activation of latent transforming growth factor beta. Cancer Metastasis Rev. 2005;24:395\u2013402.","journal-title":"Cancer Metastasis Rev"},{"key":"347_CR38","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/cncr.10774","volume":"95","author":"E Sivridis","year":"2002","unstructured":"Sivridis E, Giatromanolaki A, Gatter KC, Harris AL, Koukourakis MI, for the T, Angiogenesis Research G. Association of hypoxia-inducible factors 1\u03b1 and 2\u03b1 with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer. 2002;95:1055\u201363.","journal-title":"Cancer"},{"key":"347_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/PGP.0b013e318182c2be","volume":"28","author":"G Goteri","year":"2009","unstructured":"Goteri G, Lucarini G, Montik N, Zizzi A, Stramazzotti D, Fabris G, Tranquilli AL, Ciavattini A. Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1alpha (HIF-1alpha), and microvessel density in endometrial tissue in women with adenomyosis. Int J Gynecol Pathol. 2009;28:157\u201363.","journal-title":"Int J Gynecol Pathol"},{"key":"347_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1359-6101(00)00018-6","volume":"12","author":"D Joyce","year":"2001","unstructured":"Joyce D, Albanese C, Steer J, Fu M, Bouzahzah B, Pestell RG. NF-kappaB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev. 2001;12:73\u201390.","journal-title":"Cytokine Growth Factor Rev"},{"key":"347_CR41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0960-7404(00)00012-8","volume":"8","author":"SA Schwartz","year":"1999","unstructured":"Schwartz SA, Hernandez A, Mark Evers B. The role of NF-kappaB\/IkappaB proteins in cancer: implications for novel treatment strategies. Surg Oncol. 1999;8:143\u201353.","journal-title":"Surg Oncol"},{"key":"347_CR42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/path.1711620403","volume":"162","author":"PA Hall","year":"1990","unstructured":"Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol. 1990;162:285\u201394.","journal-title":"J Pathol"},{"key":"347_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000068380","volume":"54","author":"AGZ Rossi","year":"2003","unstructured":"Rossi AGZ, Soares Jr JM, Motta ELA, Sim\u00f5es MJ, Oliveira-Filho RM, Haidar MA, Rodrigues de Lima G, Baracat EC. Metoclopramide-induced hyperprolactinemia affects mouse endometrial morphology. Gynecol Obstet Investig. 2003;54:185\u201390.","journal-title":"Gynecol Obstet Investig"},{"key":"347_CR44","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/mrd.22489","volume":"82","author":"J Schindelin","year":"2015","unstructured":"Schindelin J, Rueden CT, Hiner MC, Eliceiri KW. The ImageJ ecosystem: an open platform for biomedical image analysis. Mol Reprod Dev. 2015;82:518\u201329.","journal-title":"Mol Reprod Dev"},{"key":"347_CR45","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","volume":"142","author":"ALL Durlinger","year":"2001","unstructured":"Durlinger ALL, Gruijters MJG, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JTJ, Grootegoed JA, Themmen APN. Anti-M\u00fcllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology. 2001;142:4891\u20139.","journal-title":"Endocrinology"},{"key":"347_CR46","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1530\/rep.1.00095","volume":"127","author":"M Myers","year":"2004","unstructured":"Myers M, Britt KL, Wreford NGM, Ebling FJP, Kerr JB. Methods for quantifying follicular numbers within the mouse ovary. Reproduction. 2004;127:569\u201380.","journal-title":"Reproduction"},{"key":"347_CR47","doi-asserted-by":"crossref","unstructured":"Ray A, Dittel BN. Isolation of mouse peritoneal cavity cells. J Vis Exp. 2010:e1488.","DOI":"10.3791\/1488"},{"key":"347_CR48","first-page":"175","volume":"35","author":"B Grzechocinska","year":"2014","unstructured":"Grzechocinska B, Gadomska H, Zygula A, Wielgos M. Application of ulipristal acetate in female patients with uterine fibroids. Neuroendocrinol Lett. 2014;35:175\u20138.","journal-title":"Neuroendocrinol Lett"},{"key":"347_CR49","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.contraception.2013.05.010","volume":"88","author":"V Brache","year":"2013","unstructured":"Brache V, Cochon L, Deniaud M, Croxatto HB. Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens. Contraception. 2013;88:611\u20138.","journal-title":"Contraception"},{"key":"347_CR50","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ejogrb.2013.03.022","volume":"169","author":"CA Huniadi","year":"2013","unstructured":"Huniadi CA, Pop OL, Antal TA, Stamatian F. The effects of ulipristal on Bax\/Bcl-2, cytochrome C, Ki-67 and cyclooxygenase-2 expression in a rat model with surgically induced endometriosis. Eur J Obstet Gynecol Reprod Biol. 2013;169:360\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"347_CR51","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/35160","volume":"391","author":"T Ross\u00e9","year":"1998","unstructured":"Ross\u00e9 T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B, Borner C. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature. 1998;391:496\u20139.","journal-title":"Nature"},{"key":"347_CR52","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1600-0897.2004.00231.x","volume":"52","author":"O Yoshino","year":"2004","unstructured":"Yoshino O, Osuga Y, Hirota Y, Koga K, Hirata T, Harada M, Morimoto C, Yano T, Nishii O, Tsutsumi O, Taketani Y. Possible pathophysiological roles of mitogen-activated protein kinases (MAPKs) in endometriosis. Am J Reprod Immunol. 2004;52:306\u201311.","journal-title":"Am J Reprod Immunol"},{"key":"347_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0171-2985(97)80025-3","volume":"198","author":"K Schulze-Osthoff","year":"1997","unstructured":"Schulze-Osthoff K, Ferrari D, Riehemann K, Wesselborg S. Regulation of NF-kappa B activation by MAP kinase cascades. Immunobiology. 1997;198:35\u201349.","journal-title":"Immunobiology"},{"key":"347_CR54","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1038\/sj.onc.1207556","volume":"23","author":"T Wada","year":"2004","unstructured":"Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene. 2004;23:2838\u201349.","journal-title":"Oncogene"},{"key":"347_CR55","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cell.2007.05.003","volume":"129","author":"GL Moldovan","year":"2007","unstructured":"Moldovan GL, Pfander B, Jentsch S. PCNA, the maestro of the replication fork. Cell. 2007;129:665\u201379.","journal-title":"Cell"},{"key":"347_CR56","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","volume":"182","author":"T Scholzen","year":"2000","unstructured":"Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311\u201322.","journal-title":"J Cell Physiol"},{"key":"347_CR57","first-page":"167","volume":"82","author":"K Yl\u00e4nen","year":"2003","unstructured":"Yl\u00e4nen K, Laatikainen T, L\u00e4hteenm\u00e4ki P, Moo-Young AJ. Subdermal progestin implant (Nestorone\u00ae) in the treatment of endometriosis: clinical response to various doses. Acta Obstet Gynecol Scand. 2003;82:167\u201372.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"347_CR58","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.fertnstert.2014.10.038","volume":"103","author":"J Donnez","year":"2015","unstructured":"Donnez J, Hudecek R, Donnez O, Matule D, Arhendt H-J, Zatik J, Kasilovskiene Z, Dumitrascu MC, Fernandez H, Barlow DH, et al. Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertil Steril. 2015;103:519\u201327. e513","journal-title":"Fertil Steril"},{"key":"347_CR59","doi-asserted-by":"publisher","first-page":"506","DOI":"10.5468\/ogs.2016.59.6.506","volume":"59","author":"SA Kim","year":"2016","unstructured":"Kim SA, Um MJ, Kim HK, Kim SJ, Moon SJ, Jung H. Study of dienogest for dysmenorrhea and pelvic pain associated with endometriosis. Obstet Gynecol Sci. 2016;59:506\u201311.","journal-title":"Obstet Gynecol Sci"},{"key":"347_CR60","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/humrep\/dep469","volume":"25","author":"T Strowitzki","year":"2010","unstructured":"Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod. 2010;25:633\u201341.","journal-title":"Hum Reprod"},{"key":"347_CR61","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejogrb.2016.07.513","volume":"209","author":"N Berlanda","year":"2017","unstructured":"Berlanda N, Somigliana E, Frattaruolo MP, Buggio L, Dridi D, Vercellini P. Surgery versus hormonal therapy for deep endometriosis: is it a choice of the physician? Eur J Obstet Gynecol Reprod Biol. 2017;209:67\u201371.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"347_CR62","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1210\/er.2005-0001","volume":"26","author":"K Chwalisz","year":"2005","unstructured":"Chwalisz K, Perez MC, Demanno D, Winkel C, Schubert G, Elger W. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr Rev. 2005;26:423\u201338.","journal-title":"Endocr Rev"},{"key":"347_CR63","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jogc.2015.11.005","volume":"38","author":"K Arendas","year":"2016","unstructured":"Arendas K, Leyland NA. Use of Ulipristal acetate for the Management of Fibroid-Related Acute Abnormal Uterine Bleeding. J Obstet Gynaecol Can. 2016;38:80\u20133.","journal-title":"J Obstet Gynaecol Can"},{"key":"347_CR64","doi-asserted-by":"publisher","first-page":"bcr2014209015","DOI":"10.1136\/bcr-2014-209015","volume":"2015","author":"L Matytsina-Quinlan","year":"2015","unstructured":"Matytsina-Quinlan L, Matytsina L. Abnormal excessive per vagina (PV) bleeding on Esmya-selective progesterone receptor modulator (SPRM) in a symptomatic patient with uterine fibroid. BMJ Case Rep. 2015;2015:bcr2014209015.","journal-title":"BMJ Case Rep"},{"key":"347_CR65","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1447-0756.2011.01778.x","volume":"38","author":"C Nagata","year":"2012","unstructured":"Nagata C, Yanagida S, Okamoto A, Morikawa A, Sugimoto K, Okamoto S, Ochiai K, Tanaka T. Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest. J Obstet Gynaecol Res. 2012;38:639\u201344.","journal-title":"J Obstet Gynaecol Res"},{"key":"347_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12325-012-0071-3","volume":"30","author":"EA Micks","year":"2013","unstructured":"Micks EA, Jensen JT. Treatment of heavy menstrual bleeding with the estradiol valerate and dienogest oral contraceptive pill. Adv Ther. 2013;30:1\u201313.","journal-title":"Adv Ther"},{"key":"347_CR67","first-page":"531","volume":"32","author":"LHR Whitaker","year":"2017","unstructured":"Whitaker LHR, Murray AA, Matthews R, Shaw G, Williams ARW, Saunders PTK, Critchley HOD. Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium. Hum Reprod. 2017;32:531\u201343.","journal-title":"Hum Reprod"},{"key":"347_CR68","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.contraception.2015.12.015","volume":"93","author":"C Jesam","year":"2016","unstructured":"Jesam C, Cochon L, Salvatierra AM, Williams A, Kapp N, Levy-Gompel D, Brache V. A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate. Contraception. 2016;93:310\u20136.","journal-title":"Contraception"},{"key":"347_CR69","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/0029-7844(96)00016-6","volume":"87","author":"S Nakamura","year":"1996","unstructured":"Nakamura S, Douchi T, Oki T, Ijuin H, Yamamoto S, Nagata Y. Relationship between sonographic endometrial thickness and progestin-induced withdrawal bleeding. Obstet Gynecol. 1996;87:722\u20135.","journal-title":"Obstet Gynecol"},{"key":"347_CR70","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3109\/09513590009167694","volume":"14","author":"C Bergeron","year":"2000","unstructured":"Bergeron C, Fox H. Low incidence of endometrial hyperplasia with acceptable bleeding patterns in women taking sequential hormone replacement therapy with dydrogesterone. Gynecol Endocrinol. 2000;14:275\u201381.","journal-title":"Gynecol Endocrinol"},{"key":"347_CR71","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.maturitas.2005.05.015","volume":"53","author":"C Quereux","year":"2006","unstructured":"Quereux C, Pornel B, Bergeron C, Ferenczy A. Continuous combined hormone replacement therapy with 1 mg 17\u03b2-oestradiol and 5 mg dydrogesterone (Femoston\u00ae-conti): endometrial safety and bleeding profile. Maturitas. 2006;53:299\u2013305.","journal-title":"Maturitas"},{"key":"347_CR72","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jmig.2013.04.020","volume":"20","author":"M Kodama","year":"2013","unstructured":"Kodama M, Onoue M, Otsuka H, Yada-Hashimoto N, Saeki N, Kodama T, Wakasa T, Funato T. Efficacy of Dienogest in thinning the endometrium before Hysteroscopic surgery. J Minim Invasive Gynecol. 2013;20:790\u20135.","journal-title":"J Minim Invasive Gynecol"},{"key":"347_CR73","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00404-016-4244-1","volume":"295","author":"AS Lagan\u00e0","year":"2017","unstructured":"Lagan\u00e0 AS, Vitale SG, Muscia V, Rossetti P, Buscema M, Triolo O, Rapisarda AMC, Giunta L, Palmara V, Granese R, et al. Endometrial preparation with Dienogest before hysteroscopic surgery: a systematic review. Arch Gynecol Obstet. 2017;295:661\u20137.","journal-title":"Arch Gynecol Obstet"},{"key":"347_CR74","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1177\/0091270011423664","volume":"52","author":"C Klipping","year":"2012","unstructured":"Klipping C, Duijkers I, Remmers A, Faustmann T, Zurth C, Klein S, Schuett B. Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women. J Clin Pharmacol. 2012;52:1704\u201313.","journal-title":"J Clin Pharmacol"},{"key":"347_CR75","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/acta.0.0670551","volume":"67","author":"V Claassen","year":"1971","unstructured":"Claassen V, Morsink L, de Wachter AM. Influence of dydrogesterone (6-dehydroretroprogesterone, Duphaston) on ovulation in the rat, rabbit and monkey. Acta Endocrinol. 1971;67:551\u201362.","journal-title":"Acta Endocrinol"},{"key":"347_CR76","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.contraception.2012.07.008","volume":"87","author":"J Endrikat","year":"2013","unstructured":"Endrikat J, Parke S, Trummer D, Serrani M, Duijkers I, Klipping C. Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study. Contraception. 2013;87:227\u201334.","journal-title":"Contraception"},{"key":"347_CR77","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1093\/humrep\/deq157","volume":"25","author":"V Brache","year":"2010","unstructured":"Brache V, Cochon L, Jesam C, Maldonado R, Salvatierra AM, Levy DP, Gainer E, Croxatto HB. Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture. Hum Reprod. 2010;25:2256\u201363.","journal-title":"Hum Reprod"},{"key":"347_CR78","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/humupd\/dmp007","volume":"15","author":"SW Guo","year":"2009","unstructured":"Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update. 2009;15:441\u201361.","journal-title":"Hum Reprod Update"},{"key":"347_CR79","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.biocel.2014.12.019","volume":"60","author":"PG Signorile","year":"2015","unstructured":"Signorile PG, Baldi A. New evidence in endometriosis. Int J Biochem Cell Biol. 2015;60:19\u201322.","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-018-0347-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12958-018-0347-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-018-0347-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T23:58:59Z","timestamp":1660780739000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-018-0347-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["347"],"URL":"https:\/\/doi.org\/10.1186\/s12958-018-0347-9","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]},"assertion":[{"value":"6 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All of the animal experiments were approved from the Animal Experimentation Ethics Committee, The Chinese University of Hong Kong.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"32"}}